<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://mpkb.org/lib/exe/css.php?s=feed" type="text/css"?>
<rss version="2.0">
    <channel xmlns:g="http://base.google.com/ns/1.0">
        <title>Marshall Protocol Knowledge Base - home:special:kidneys_at_work</title>
        <description></description>
        <link>https://mpkb.org/</link>
        <lastBuildDate>Tue, 07 Apr 2026 16:30:22 +0000</lastBuildDate>
        <generator>FeedCreator 1.8</generator>
        <image>
            <url>https://mpkb.org/_media/wiki/dokuwiki.svg</url>
            <title>Marshall Protocol Knowledge Base</title>
            <link>https://mpkb.org/</link>
        </image>
        <item>
            <title>Kidney Capacity and Function</title>
            <link>https://mpkb.org/home/special/kidneys_at_work/kidney_function?rev=1663137434&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;10.12.2018&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 20:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 20:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Further reading =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Further reading =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;Elevations in serum creatinine with RAAS blockade: why isn&amp;#039;t it a sign of kidney injury?&amp;#160; &amp;#160;(({{&lt;strong class=&quot;diff-mark&quot;&gt;pubmed&lt;/strong&gt;&amp;gt;long:18695383}}))&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;Elevations in serum creatinine with RAAS blockade: why isn&amp;#039;t it a sign of kidney injury?&amp;#160; &amp;#160;(({{&lt;strong class=&quot;diff-mark&quot;&gt;pmid&lt;/strong&gt;&amp;gt;long:18695383}}))&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.&amp;#160; &amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pubmed&lt;/strong&gt;&amp;gt;long:11768722}}))&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.&amp;#160; &amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pmid&lt;/strong&gt;&amp;gt;long:11768722}}))&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;Role of renin-angiotensin system in inflammation, immunity and aging.&amp;#160; &amp;#160;(({{&lt;strong class=&quot;diff-mark&quot;&gt;pubmed&lt;/strong&gt;&amp;gt;long:22283774}}))&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;Role of renin-angiotensin system in inflammation, immunity and aging.&amp;#160; &amp;#160;(({{&lt;strong class=&quot;diff-mark&quot;&gt;pmid&lt;/strong&gt;&amp;gt;long:22283774}}))&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).&amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pubmed&lt;/strong&gt;&amp;gt;long:27086671}}))&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).&amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pmid&lt;/strong&gt;&amp;gt;long:27086671}}))&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Giving the kidneys chance to recover =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Giving the kidneys chance to recover =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 100:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 100:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;==== Activation of RAS ====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;==== Activation of RAS ====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;from Nangaku M et al. J Am Soc Nephrol. (2006)&amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pubmed&lt;/strong&gt;&amp;gt;long:16291837}}))&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;from Nangaku M et al. J Am Soc Nephrol. (2006)&amp;#160; (({{&lt;strong class=&quot;diff-mark&quot;&gt;pmid&lt;/strong&gt;&amp;gt;long:16291837}}))&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;lt;blockquote&amp;gt;Among various vasoactive substances, local activation of RAS is especially important because it can lead to constriction of efferent arterioles, hypoperfusion of postglomerular peritubular capillaries, and subsequent hypoxia of the tubulointerstitium in the downstream compartment. To clarify the mechanism of these effects, we used a remnant kidney model in rats induced by ligation of renal artery branches, in which RAS is markedly activated. Our computer-assisted morphologic analysis demonstrated narrowing and distortion of peritubular capillaries with decreased blood flow and hypoxia in a very early phase in this model, before the development of structural kidney damage (37). In addition, angiotensin II damages endothelial cells directly: Administration of angiotensin II to rats causes the loss of peritubular capillaries, an effect that is ameliorated by receptor blockade (38,39). A second important mechanism of angiotensin II–induced ischemia is inefficient cellular respiration and hypoxia via oxidative stress, which is detailed below. Thus, angiotensin II induces tubulointerstitial hypoxia via both hemodynamic and nonhemodynamic mechanisms. Intrarenal vasoconstriction may also occur secondary to increased local endothelin or a local loss of vasodilating nitric oxide (NO).&amp;lt;/blockquote&amp;gt;&amp;#160; &amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;lt;blockquote&amp;gt;Among various vasoactive substances, local activation of RAS is especially important because it can lead to constriction of efferent arterioles, hypoperfusion of postglomerular peritubular capillaries, and subsequent hypoxia of the tubulointerstitium in the downstream compartment. To clarify the mechanism of these effects, we used a remnant kidney model in rats induced by ligation of renal artery branches, in which RAS is markedly activated. Our computer-assisted morphologic analysis demonstrated narrowing and distortion of peritubular capillaries with decreased blood flow and hypoxia in a very early phase in this model, before the development of structural kidney damage (37). In addition, angiotensin II damages endothelial cells directly: Administration of angiotensin II to rats causes the loss of peritubular capillaries, an effect that is ameliorated by receptor blockade (38,39). A second important mechanism of angiotensin II–induced ischemia is inefficient cellular respiration and hypoxia via oxidative stress, which is detailed below. Thus, angiotensin II induces tubulointerstitial hypoxia via both hemodynamic and nonhemodynamic mechanisms. Intrarenal vasoconstriction may also occur secondary to increased local endothelin or a local loss of vasodilating nitric oxide (NO).&amp;lt;/blockquote&amp;gt;&amp;#160; &amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 119:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 119:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Another citation reports inhibition of STAT1 by binding with unliganded VDR.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Another citation reports inhibition of STAT1 by binding with unliganded VDR.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;[[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0078695&amp;amp;type=printable|NF-kB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons]]&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;[[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0078695&amp;amp;type=printable|NF-kB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;[[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.jimmunol.org/content/early/2014/05/10/jimmunol.1302296|Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α]]&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;[[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.jimmunol.org/content/early/2014/05/10/jimmunol.1302296|Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 184:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 184:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://www.youtube.com/watch?v=BVUeCLt68Ik&amp;#160; Khan academy (14 min.)&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://www.youtube.com/watch?v=BVUeCLt68Ik&amp;#160; Khan academy (14 min.)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;--- //Sallie Q 02.17.2017//&amp;#160; created page arranging material posted by Jigsaw and approved by him&lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;RAS refs&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;RAS refs&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 193:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 193:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;other refs went to, one went nowhere&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;other refs went to, one went nowhere&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.kidney-international.org/ &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.kidney-international.org/ &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;also CO2 blood test&amp;#160;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.kidney-international.org/&amp;#160; for elsewhere if not there &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;also CO2 blood test&amp;#160;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.kidney-international.org/&amp;#160; for elsewhere if not there &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;amp; Hyperkalemia&amp;#160;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.medicinenet.com/hyperkalemia/page4.htm&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;amp; Hyperkalemia&amp;#160;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.medicinenet.com/hyperkalemia/page4.htm&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;hyper K management&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.fpnotebook.com/renal/potassium/hyprklmmngmnt.htm&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;hyper K management&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.fpnotebook.com/renal/potassium/hyprklmmngmnt.htm&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Bicarbonate supplementation slows progression of CKD and improves nutritional status.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Bicarbonate supplementation slows progression of CKD and improves nutritional status.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://www.ncbi.nlm.nih.gov/pubmed/19608703&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://www.ncbi.nlm.nih.gov/pubmed/19608703&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Metabolic Acidosis&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Metabolic Acidosis&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/acid-base-regulation-and-disorders/metabolic-acidosis&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/acid-base-regulation-and-disorders/metabolic-acidosis&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;** Mechanism of acid-induced bone resorption.&amp;#160; &amp;#160; &amp;#160; 15199293&amp;#160; &amp;#160; &amp;#160; &amp;#160;15199293&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;** Mechanism of acid-induced bone resorption.&amp;#160; &amp;#160; &amp;#160; 15199293&amp;#160; &amp;#160; &amp;#160; &amp;#160;15199293&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Metabolic, but not respiratory, acidosis increases bone PGE2 levels and calcium release&amp;#160; &amp;#160; &amp;#160; 11704556&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Metabolic, but not respiratory, acidosis increases bone PGE2 levels and calcium release&amp;#160; &amp;#160; &amp;#160; 11704556&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;hyper K&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://emedicine.medscape.com/article/241185-overview#a0104 &lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;hyper K&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://emedicine.medscape.com/article/241185-overview#a0104 &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;hyper K&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.unitedhealthdirectory.com/diseases-and-conditions/hyperphosphatemia/&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;hyper K&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.unitedhealthdirectory.com/diseases-and-conditions/hyperphosphatemia/&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;tetany [defn]&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.medicinenet.com/script/main/art.asp?articlekey=13312&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;tetany [defn]&amp;#160;&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.medicinenet.com/script/main/art.asp?articlekey=13312&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://en.wikipedia.org/wiki/Tumor_lysis_syndrome&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;https://en.wikipedia.org/wiki/Tumor_lysis_syndrome&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;===== References =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 06:37:14 +0000</pubDate>
        </item>
    </channel>
</rss>
